Papers: 14 Mar 2014 - 21 Mar 2014
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting.
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
Transverse Myelitis Associated With an Itchy Rash and HyperCkemia: Neuromyelitis Optica Associated With Dermatitis Herpetiformis.
Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis.
Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases.